Denis Furling

6.2k total citations
94 papers, 4.2k citations indexed

About

Denis Furling is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Denis Furling has authored 94 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Molecular Biology, 61 papers in Cellular and Molecular Neuroscience and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Denis Furling's work include Genetic Neurodegenerative Diseases (60 papers), Muscle Physiology and Disorders (56 papers) and Mitochondrial Function and Pathology (22 papers). Denis Furling is often cited by papers focused on Genetic Neurodegenerative Diseases (60 papers), Muscle Physiology and Disorders (56 papers) and Mitochondrial Function and Pathology (22 papers). Denis Furling collaborates with scholars based in France, Canada and United States. Denis Furling's co-authors include Gillian Butler‐Browne, Vincent Mouly, Jack Puymirat, Arnaud F. Klein, Virginie Jacquemin, Anne Bigot, Geneviève Gourdon, Kamel Mamchaoui, Glenn E. Morris and Nikolaos P. Mastroyiannopoulos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Denis Furling

92 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denis Furling France 39 3.7k 1.7k 432 424 403 94 4.2k
Stephen J. Crocker United States 34 2.0k 0.5× 903 0.5× 233 0.5× 141 0.3× 648 1.6× 72 4.1k
Erik‐Jan Kamsteeg Netherlands 32 2.2k 0.6× 704 0.4× 206 0.5× 313 0.7× 343 0.9× 124 3.2k
Marı́a T. Berciano Spain 39 3.2k 0.9× 803 0.5× 657 1.5× 77 0.2× 324 0.8× 139 5.1k
Ronald D. Cohn United States 24 3.4k 0.9× 610 0.4× 376 0.9× 889 2.1× 888 2.2× 38 4.4k
Martin Brockington United Kingdom 34 3.7k 1.0× 814 0.5× 460 1.1× 761 1.8× 362 0.9× 55 4.1k
Yun Yuan China 27 1.8k 0.5× 730 0.4× 277 0.6× 344 0.8× 293 0.7× 272 3.0k
Donal MacGrogan United States 30 2.1k 0.6× 321 0.2× 143 0.3× 355 0.8× 564 1.4× 45 3.9k
Patrick Küry Germany 34 1.4k 0.4× 717 0.4× 277 0.6× 88 0.2× 181 0.4× 119 3.2k
Anne Picard Italy 15 2.9k 0.8× 415 0.2× 176 0.4× 257 0.6× 1.1k 2.8× 32 3.6k
Svetlana Bezprozvannaya United States 27 3.3k 0.9× 436 0.3× 215 0.5× 528 1.2× 414 1.0× 43 4.0k

Countries citing papers authored by Denis Furling

Since Specialization
Citations

This map shows the geographic impact of Denis Furling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denis Furling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denis Furling more than expected).

Fields of papers citing papers by Denis Furling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denis Furling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denis Furling. The network helps show where Denis Furling may publish in the future.

Co-authorship network of co-authors of Denis Furling

This figure shows the co-authorship network connecting the top 25 collaborators of Denis Furling. A scholar is included among the top collaborators of Denis Furling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denis Furling. Denis Furling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonnet, H, Ekaterina Boyarchuk, Denis Furling, et al.. (2025). Small nucleolar RNAs promote the restoration of muscle differentiation defects in cells from myotonic dystrophy type 1. Nucleic Acids Research. 53(6). 1 indexed citations
2.
Gilbert, Jessica R., Arnaud F. Klein, Amos Gutnick, et al.. (2024). 440P Nonclinical data for PGN-EDODM1 demonstrated nuclear delivery, mechanistic and meaningful activity for the potential treatment of DM1. Neuromuscular Disorders. 43. 104441.515–104441.515. 1 indexed citations
3.
Agbulut, Onnik, et al.. (2023). Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology. 50(9). 749–756. 3 indexed citations
4.
Lainé, Jeanne, Hélène Polvèche, Camille Nicoleau, et al.. (2022). MBNL‐dependent impaired development within the neuromuscular system in myotonic dystrophy type 1. Neuropathology and Applied Neurobiology. 49(1). e12876–e12876. 9 indexed citations
5.
Arandel, Ludovic, Arnaud F. Klein, Frédérique Rau, et al.. (2022). Reversal of RNA toxicity in myotonic dystrophy via a decoy RNA-binding protein with high affinity for expanded CUG repeats. Nature Biomedical Engineering. 6(2). 207–220. 25 indexed citations
6.
7.
Moulay, Gilles, Jeanne Lainé, Masayuki Nakamori, et al.. (2020). Alternative splicing of clathrin heavy chain contributes to the switch from coated pits to plaques. The Journal of Cell Biology. 219(9). 34 indexed citations
8.
Wahbi, Karim & Denis Furling. (2019). Cardiovascular manifestations of Myotonic Dystrophy. SPIRE - Sciences Po Institutional REpository. 1 indexed citations
9.
Sellier, Chantal, Estefanía Cerro-Herreros, Markus Blatter, et al.. (2018). rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences. Nature Communications. 9(1). 2009–2009. 57 indexed citations
10.
Agtmaal, Ellen L. van, Marieke Willemse, Sarah A. Cumming, et al.. (2017). CRISPR/Cas9-Induced (CTG⋅CAG) n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing. Molecular Therapy. 25(1). 24–43. 95 indexed citations
11.
Laurent, François-Xavier, et al.. (2011). New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats. Nucleic Acids Research. 40(7). 3159–3171. 61 indexed citations
12.
Koutsoulidou, Andrie, Nikolaos P. Mastroyiannopoulos, Denis Furling, James B. Uney, & Leonidas A. Phylactou. (2011). Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Developmental Biology. 11(1). 34–34. 150 indexed citations
13.
Mulders, Susan, Walther J. A. A. van den Broek, Thurman M. Wheeler, et al.. (2009). Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proceedings of the National Academy of Sciences. 106(33). 13915–13920. 204 indexed citations
14.
15.
Holt, Ian, Virginie Jacquemin, Majid Fardaei, et al.. (2008). Muscleblind-Like Proteins. American Journal Of Pathology. 174(1). 216–227. 59 indexed citations
16.
Torrente, Yvan, M. Belicchi, Maurilio Sampaolesi, et al.. (2004). Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. Journal of Clinical Investigation. 114(2). 182–195. 42 indexed citations
17.
Jacquemin, Virginie, Denis Furling, Anne Bigot, Gillian Butler‐Browne, & Vincent Mouly. (2004). IGF-1 induces human myotube hypertrophy by increasing cell recruitment. Experimental Cell Research. 299(1). 148–158. 106 indexed citations
18.
Furling, Denis, et al.. (2003). Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions. Gene Therapy. 10(9). 795–802. 56 indexed citations
19.
Furling, Denis, et al.. (2001). Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscular Disorders. 11(8). 728–735. 79 indexed citations
20.
Skuk, Daniel, Denis Furling, Jean‐Pierre Bouchard, et al.. (1999). Transplantation of Human Myoblasts in SCID Mice as a Potential Muscular Model for Myotonic Dystrophy. Journal of Neuropathology & Experimental Neurology. 58(9). 921–931. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen J. Crocker Breakdown of academic impact, for papers by Erik‐Jan Kamsteeg Breakdown of academic impact, for papers by Marı́a T. Berciano Breakdown of academic impact, for papers by Ronald D. Cohn Breakdown of academic impact, for papers by Martin Brockington Breakdown of academic impact, for papers by Yun Yuan Breakdown of academic impact, for papers by Donal MacGrogan Breakdown of academic impact, for papers by Patrick Küry Breakdown of academic impact, for papers by Anne Picard Breakdown of academic impact, for papers by Svetlana Bezprozvannaya
Rankless by CCL
2026